Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Malcolm Peet

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
The British Journal of Psychiatry. Supplement|April 2, 2004
Diet, diabetes and schizophrenia: review and hypothesisMalcolm Peet
Prostaglandins, Leukotrienes, and Essential Fatty Acids|August 29, 2006
The metabolic syndrome, omega-3 fatty acids and inflammatory processes in relation to schizophreniaMalcolm Peet
Prostaglandins, Leukotrienes, and Essential Fatty Acids|November 19, 2003
Eicosapentaenoic acid in the treatment of schizophrenia and depression: rationale and preliminary double-blind clinical trial resultsMalcolm Peet
The Israel Journal of Psychiatry and Related Sciences|July 1, 2008
Omega-3 polyunsaturated fatty acids in the treatment of schizophreniaMalcolm Peet
The British Journal of Psychiatry : the Journal of Mental Science|May 5, 2004
International variations in the outcome of schizophrenia and the prevalence of depression in relation to national dietary practices: an ecological analysisMalcolm Peet
World Review of Nutrition and Dietetics|September 10, 2005
Nutrition and schizophreniaMalcolm Peet
Nutrition and Health|January 2, 2004
Nutrition and schizophrenia: an epidemiological and clinical perspectiveMalcolm Peet
Prostaglandins, Leukotrienes, and Essential Fatty Acids|March 26, 2004
Nutrition and schizophrenia: beyond omega-3 fatty acidsMalcolm Peet
Nutritional Neuroscience|February 3, 2005
Dietary sugar and polyunsaturated fatty acid consumption as predictors of severity of schizophrenia symptomsCaroline Stokes, Malcolm Peet
Drugs|May 24, 2005
Omega-3 fatty acids in the treatment of psychiatric disordersMalcolm Peet, Caroline Stokes
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
The British Journal of Psychiatry. Supplement|April 2, 2004
Diet, diabetes and schizophrenia: review and hypothesisMalcolm Peet
Prostaglandins, Leukotrienes, and Essential Fatty Acids|August 29, 2006
The metabolic syndrome, omega-3 fatty acids and inflammatory processes in relation to schizophreniaMalcolm Peet
Prostaglandins, Leukotrienes, and Essential Fatty Acids|November 19, 2003
Eicosapentaenoic acid in the treatment of schizophrenia and depression: rationale and preliminary double-blind clinical trial resultsMalcolm Peet
The Israel Journal of Psychiatry and Related Sciences|July 1, 2008
Omega-3 polyunsaturated fatty acids in the treatment of schizophreniaMalcolm Peet
The British Journal of Psychiatry : the Journal of Mental Science|May 5, 2004
International variations in the outcome of schizophrenia and the prevalence of depression in relation to national dietary practices: an ecological analysisMalcolm Peet
World Review of Nutrition and Dietetics|September 10, 2005
Nutrition and schizophreniaMalcolm Peet
Nutrition and Health|January 2, 2004
Nutrition and schizophrenia: an epidemiological and clinical perspectiveMalcolm Peet
Prostaglandins, Leukotrienes, and Essential Fatty Acids|March 26, 2004
Nutrition and schizophrenia: beyond omega-3 fatty acidsMalcolm Peet
Nutritional Neuroscience|February 3, 2005
Dietary sugar and polyunsaturated fatty acid consumption as predictors of severity of schizophrenia symptomsCaroline Stokes, Malcolm Peet
Drugs|May 24, 2005
Omega-3 fatty acids in the treatment of psychiatric disordersMalcolm Peet, Caroline Stokes
Pageof 2